Market research Reports and Industry Analysis Reports

Request a free Sample

Detailed TOC of Global Neurological Biomarkers Market 2016-2020

PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Biomarker assays kits
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis:
PART 06: Market segmentation by indication
• AD
• PD
• ASD
• MS
PART 07: Market segmentation by application
• Genomics-based biomarkers
• Proteomics-based biomarkers
• Metabolomics-based biomarkers
• Imaging-based biomarkers
• Emerging application areas
PART 08: Market segmentation by services
• Services
PART 09: Market segmentation by end-user
• Hospitals
• Diagnostic and research laboratories
PART 10: Geographical segmentation
• Neurological biomarkers market in Americas
• Neurological biomarkers market in EMEA
• Neurological biomarkers market in APAC
PART 11: Market drivers
• Increasing low-cost clinical trials in developing countries
• Growing personalized medicine for neurological disorders
• Increasing focus toward drug discovery applications
PART 12: Impact of drivers
PART 13: Market challenges
• Unmet market needs of effective validation of biomarkers
• Reproducibility of biomarkers and tests leading to discrepancies
• Delay in market launch
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Integrated biology approach will be the key focus area
• Development of novel radiotracers for neuro biomarkers that aid diagnostic and clinical applications for diseases
• Evolution of miRNA
PART 16: Vendor landscape
• Competitive scenario
PART 17: Key vendor analysis
• Geographic presence — Key vendor analysis
• Myriad RBM
• Proteome Sciences
• QIAGEN
• Thermo Fisher Scientific
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Key biomarker technology platforms
Exhibit 03: Global neurological biomarkers market (2016-2020) ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Market segmentation by indication
Exhibit 06: Market opportunities in the major indications
Exhibit 07: Global neurological biomarkers market segmentation by application 2015
Exhibit 08: Market opportunities in key applications
Exhibit 09: Impact mapping of neurological biomarker services
Exhibit 10: Opportunity analysis of biomarker services
Exhibit 11: Global neurological biomarkers market 2015
Exhibit 12: Market overview in Americas 2015
Exhibit 13: Neurological biomarkers market in Americas ($ billions)
Exhibit 14: Market overview in EMEA 2015
Exhibit 15: Neurological biomarkers market in EMEA ($ billions)
Exhibit 16: Market overview in APAC 2015
Exhibit 17: Neurological biomarkers market in APAC ($ millions)
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Competitive structure analysis of global neurological biomarkers market 2015
Exhibit 21: Market penetration of key neurological biomarkers manufacturers 2015
Exhibit 22: Strategic success factors of companies in global neurological biomarkers market
Exhibit 23: Regional analysis of key vendors
Exhibit 24: Myriad RBM: Profile
Exhibit 25: Myriad RBM: Strength analysis
Exhibit 26: Myriad RBM: Growth strategy matrix
Exhibit 27: Myriad RBM: Opportunity assessment analysis
Exhibit 28: Proteome Sciences: Profile
Exhibit 29: Proteome Sciences: Strength analysis
Exhibit 30: Proteome Sciences: Growth strategy matrix
Exhibit 31: Proteome Sciences: Opportunity assessment
Exhibit 32: QIAGEN: Profile
Exhibit 33: QIAGEN: Strength analysis
Exhibit 34: QIAGEN: Growth strategy matrix
Exhibit 35: QIAGEN: Opportunity assessment
Exhibit 36: Thermo Fisher Scientific: Profile
Exhibit 37: Thermo Fisher Scientific: Strength analysis
Exhibit 38: Thermo Fisher Scientific: Growth strategy matrix
Exhibit 39: Thermo Fisher Scientific: Growth opportunity assessment

Keyplayers in Global Neurological Biomarkers Market 2016-2020

Myriad RBM, Proteome Sciences, QIAGEN, Thermo Fisher Scientific, AbaStar MDx, Abiant, Acumen Pharmaceuticals, Aepodia, Alseres Pharmaceuticals, Athena Diagnostics, Banyan Biomarkers, Cisbio Bioassays, Diagenic, Proteosys, Psynova Neurotech.

REQUEST TABLES & FIGURES MENTIONED IN THIS REPORT

+1
United States+1
Afghanistan (‫افغانستان‬‎)+93
Albania (Shqipëri)+355
Algeria (‫الجزائر‬‎)+213
American Samoa+1684
Andorra+376
Angola+244
Anguilla+1264
Antigua and Barbuda+1268
Argentina+54
Armenia (Հայաստան)+374
Aruba+297
Australia+61
Austria (Österreich)+43
Azerbaijan (Azərbaycan)+994
Bahamas+1242
Bahrain (‫البحرين‬‎)+973
Bangladesh (বাংলাদেশ)+880
Barbados+1246
Belarus (Беларусь)+375
Belgium (België)+32
Belize+501
Benin (Bénin)+229
Bermuda+1441
Bhutan (འབྲུག)+975
Bolivia+591
Bosnia and Herzegovina (Босна и Херцеговина)+387
Botswana+267
Brazil (Brasil)+55
British Indian Ocean Territory+246
British Virgin Islands+1284
Brunei+673
Bulgaria (България)+359
Burkina Faso+226
Burundi (Uburundi)+257
Cambodia (កម្ពុជា)+855
Cameroon (Cameroun)+237
Canada+1
Cape Verde (Kabu Verdi)+238
Caribbean Netherlands+599
Cayman Islands+1345
Central African Republic (République centrafricaine)+236
Chad (Tchad)+235
Chile+56
China (中国)+86
Christmas Island+61
Cocos (Keeling) Islands+61
Colombia+57
Comoros (‫جزر القمر‬‎)+269
Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
Congo (Republic) (Congo-Brazzaville)+242
Cook Islands+682
Costa Rica+506
Côte d’Ivoire+225
Croatia (Hrvatska)+385
Cuba+53
Curaçao+599
Cyprus (Κύπρος)+357
Czech Republic (Česká republika)+420
Denmark (Danmark)+45
Djibouti+253
Dominica+1767
Dominican Republic (República Dominicana)+1
Ecuador+593
Egypt (‫مصر‬‎)+20
El Salvador+503
Equatorial Guinea (Guinea Ecuatorial)+240
Eritrea+291
Estonia (Eesti)+372
Ethiopia+251
Falkland Islands (Islas Malvinas)+500
Faroe Islands (Føroyar)+298
Fiji+679
Finland (Suomi)+358
France+33
French Guiana (Guyane française)+594
French Polynesia (Polynésie française)+689
Gabon+241
Gambia+220
Georgia (საქართველო)+995
Germany (Deutschland)+49
Ghana (Gaana)+233
Gibraltar+350
Greece (Ελλάδα)+30
Greenland (Kalaallit Nunaat)+299
Grenada+1473
Guadeloupe+590
Guam+1671
Guatemala+502
Guernsey+44
Guinea (Guinée)+224
Guinea-Bissau (Guiné Bissau)+245
Guyana+592
Haiti+509
Honduras+504
Hong Kong (香港)+852
Hungary (Magyarország)+36
Iceland (Ísland)+354
India (भारत)+91
Indonesia+62
Iran (‫ایران‬‎)+98
Iraq (‫العراق‬‎)+964
Ireland+353
Isle of Man+44
Israel (‫ישראל‬‎)+972
Italy (Italia)+39
Jamaica+1
Japan (日本)+81
Jersey+44
Jordan (‫الأردن‬‎)+962
Kazakhstan (Казахстан)+7
Kenya+254
Kiribati+686
Kosovo+383
Kuwait (‫الكويت‬‎)+965
Kyrgyzstan (Кыргызстан)+996
Laos (ລາວ)+856
Latvia (Latvija)+371
Lebanon (‫لبنان‬‎)+961
Lesotho+266
Liberia+231
Libya (‫ليبيا‬‎)+218
Liechtenstein+423
Lithuania (Lietuva)+370
Luxembourg+352
Macau (澳門)+853
Macedonia (FYROM) (Македонија)+389
Madagascar (Madagasikara)+261
Malawi+265
Malaysia+60
Maldives+960
Mali+223
Malta+356
Marshall Islands+692
Martinique+596
Mauritania (‫موريتانيا‬‎)+222
Mauritius (Moris)+230
Mayotte+262
Mexico (México)+52
Micronesia+691
Moldova (Republica Moldova)+373
Monaco+377
Mongolia (Монгол)+976
Montenegro (Crna Gora)+382
Montserrat+1664
Morocco (‫المغرب‬‎)+212
Mozambique (Moçambique)+258
Myanmar (Burma) (မြန်မာ)+95
Namibia (Namibië)+264
Nauru+674
Nepal (नेपाल)+977
Netherlands (Nederland)+31
New Caledonia (Nouvelle-Calédonie)+687
New Zealand+64
Nicaragua+505
Niger (Nijar)+227
Nigeria+234
Niue+683
Norfolk Island+672
North Korea (조선 민주주의 인민 공화국)+850
Northern Mariana Islands+1670
Norway (Norge)+47
Oman (‫عُمان‬‎)+968
Pakistan (‫پاکستان‬‎)+92
Palau+680
Palestine (‫فلسطين‬‎)+970
Panama (Panamá)+507
Papua New Guinea+675
Paraguay+595
Peru (Perú)+51
Philippines+63
Poland (Polska)+48
Portugal+351
Puerto Rico+1
Qatar (‫قطر‬‎)+974
Réunion (La Réunion)+262
Romania (România)+40
Russia (Россия)+7
Rwanda+250
Saint Barthélemy+590
Saint Helena+290
Saint Kitts and Nevis+1869
Saint Lucia+1758
Saint Martin (Saint-Martin (partie française))+590
Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
Saint Vincent and the Grenadines+1784
Samoa+685
San Marino+378
São Tomé and Príncipe (São Tomé e Príncipe)+239
Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
Senegal (Sénégal)+221
Serbia (Србија)+381
Seychelles+248
Sierra Leone+232
Singapore+65
Sint Maarten+1721
Slovakia (Slovensko)+421
Slovenia (Slovenija)+386
Solomon Islands+677
Somalia (Soomaaliya)+252
South Africa+27
South Korea (대한민국)+82
South Sudan (‫جنوب السودان‬‎)+211
Spain (España)+34
Sri Lanka (ශ්‍රී ලංකාව)+94
Sudan (‫السودان‬‎)+249
Suriname+597
Svalbard and Jan Mayen+47
Swaziland+268
Sweden (Sverige)+46
Switzerland (Schweiz)+41
Syria (‫سوريا‬‎)+963
Taiwan (台灣)+886
Tajikistan+992
Tanzania+255
Thailand (ไทย)+66
Timor-Leste+670
Togo+228
Tokelau+690
Tonga+676
Trinidad and Tobago+1868
Tunisia (‫تونس‬‎)+216
Turkey (Türkiye)+90
Turkmenistan+993
Turks and Caicos Islands+1649
Tuvalu+688
U.S. Virgin Islands+1340
Uganda+256
Ukraine (Україна)+380
United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
United Kingdom+44
United States+1
Uruguay+598
Uzbekistan (Oʻzbekiston)+998
Vanuatu+678
Vatican City (Città del Vaticano)+39
Venezuela+58
Vietnam (Việt Nam)+84
Wallis and Futuna (Wallis-et-Futuna)+681
Western Sahara (‫الصحراء الغربية‬‎)+212
Yemen (‫اليمن‬‎)+967
Zambia+260
Zimbabwe+263
Åland Islands+358

Security Code

We ensure/ offer complete security of your personal

Global Neurological Biomarkers Market 2016-2020

Detailed TOC of Global Neurological Biomarkers Market 2016-2020

Keyplayers in Global Neurological Biomarkers Market 2016-2020

Our Clients

Features

Type of License

Single User

Multi User

Enterprise User

Features		Type of License
Features		Single User	Multi User	Enterprise User
Pricing		US$ 2500	US$	US$ 4000
Number of Users Who can Access the Report		1 user only	2 to 6 users	Unlimited access within the organization
Free Customization		20 hours	40 hours	60 hours
Duration of Free Analyst Support		3 months post purchase	6 months post purchase	12 months post purchase
Direct access to the Analyst Team (through calls/email)
Deliverable Format	PDF
	Excel
	Power Point
Discount on Your Next Purchase (applicable to 1 report only for the same license type)		No Discount	15%	25%
Permission to Print the Report